Cardiff Oncology, Inc. (CRDF:NASDAQ) closed at $0.907 on October 23, 2026, down 2.23% on the day. The stock trades 72.6% below its 52-week high of $3.31 and 19.4% above its 52-week low of $0.760. Over the past year, it lost 59.3%. Cardiff Oncology, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, CRDF closed higher on 114 days (45%). Its best day was September 10, 2026 (+15.24%) and its worst was July 15, 2026 (-32.06%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 1 time.
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.
Find more stocks like CRDF with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.